These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20639912)

  • 1. Parkinson disease: Progress towards a molecular biomarker for Parkinson disease.
    Foulds P; Mann DM; Mitchell JD; Allsop D
    Nat Rev Neurol; 2010 Jul; 6(7):359-61. PubMed ID: 20639912
    [No Abstract]   [Full Text] [Related]  

  • 2. α-Synuclein and DJ-1 as potential biological fluid biomarkers for Parkinson's Disease.
    Waragai M; Sekiyama K; Sekigawa A; Takamatsu Y; Fujita M; Hashimoto M
    Int J Mol Sci; 2010 Oct; 11(11):4257-66. PubMed ID: 21151436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical premotor biomarkers for Parkinson's disease.
    Mollenhauer B; Zhang J
    Mov Disord; 2012 Apr; 27(5):644-50. PubMed ID: 22508282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers in Parkinson's disease: a funder's perspective.
    Frasier M; Chowdhury S; Eberling J; Sherer T
    Biomark Med; 2010 Oct; 4(5):723-9. PubMed ID: 20945984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.
    Shi M; Zabetian CP; Hancock AM; Ginghina C; Hong Z; Yearout D; Chung KA; Quinn JF; Peskind ER; Galasko D; Jankovic J; Leverenz JB; Zhang J
    Neurosci Lett; 2010 Aug; 480(1):78-82. PubMed ID: 20540987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease.
    Hong Z; Shi M; Chung KA; Quinn JF; Peskind ER; Galasko D; Jankovic J; Zabetian CP; Leverenz JB; Baird G; Montine TJ; Hancock AM; Hwang H; Pan C; Bradner J; Kang UJ; Jensen PH; Zhang J
    Brain; 2010 Mar; 133(Pt 3):713-26. PubMed ID: 20157014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems associated with fluid biomarkers for Parkinson's disease.
    Nyhlén J; Constantinescu R; Zetterberg H
    Biomark Med; 2010 Oct; 4(5):671-81. PubMed ID: 20945980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function.
    Shi M; Furay AR; Sossi V; Aasly JO; Armaly J; Wang Y; Wszolek ZK; Uitti RJ; Hasegawa K; Yokoyama T; Zabetian CP; Leverenz JB; Stoessl AJ; Zhang J
    Neurobiol Aging; 2012 Apr; 33(4):836.e5-7. PubMed ID: 22019052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the DJ-1 protein in the serum of Chinese patients with Parkinson's disease.
    An C; Pu X; Xiao W; Zhang H
    Neurosci Lett; 2018 Feb; 665():236-239. PubMed ID: 29241707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease.
    Lin X; Cook TJ; Zabetian CP; Leverenz JB; Peskind ER; Hu SC; Cain KC; Pan C; Edgar JS; Goodlett DR; Racette BA; Checkoway H; Montine TJ; Shi M; Zhang J
    Sci Rep; 2012; 2():954. PubMed ID: 23233873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid biomarkers in Parkinson disease.
    Parnetti L; Castrioto A; Chiasserini D; Persichetti E; Tambasco N; El-Agnaf O; Calabresi P
    Nat Rev Neurol; 2013 Mar; 9(3):131-40. PubMed ID: 23419373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control.
    Stewart T; Sui YT; Gonzalez-Cuyar LF; Wong DT; Akin DM; Tumas V; Aasly J; Ashmore E; Aro P; Ginghina C; Korff A; Zabetian CP; Leverenz JB; Shi M; Zhang J
    Neurobiol Aging; 2014 Feb; 35(2):418-20. PubMed ID: 24041968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease.
    Devic I; Hwang H; Edgar JS; Izutsu K; Presland R; Pan C; Goodlett DR; Wang Y; Armaly J; Tumas V; Zabetian CP; Leverenz JB; Shi M; Zhang J
    Brain; 2011 Jul; 134(Pt 7):e178. PubMed ID: 21349902
    [No Abstract]   [Full Text] [Related]  

  • 14. [The significance of oxidized DJ-1 protein (oxDJ-1) as a biomarker for Parkinson's disease].
    Ogawa I; Saito Y; Saigoh K; Hosoi Y; Mitsui Y; Noguchi N; Kusunoki S
    Brain Nerve; 2014 Apr; 66(4):471-7. PubMed ID: 24748095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease.
    Waragai M; Wei J; Fujita M; Nakai M; Ho GJ; Masliah E; Akatsu H; Yamada T; Hashimoto M
    Biochem Biophys Res Commun; 2006 Jul; 345(3):967-72. PubMed ID: 16707095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls.
    Herbert MK; Eeftens JM; Aerts MB; Esselink RA; Bloem BR; Kuiperij HB; Verbeek MM
    Parkinsonism Relat Disord; 2014 Jan; 20(1):112-5. PubMed ID: 24075122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DJ-1 concentration in cerebrospinal fluid does not differentiate among Parkinsonian syndromes.
    Salvesen L; Bech S; Lokkegaard A; Hjermind LE; Nielsen JE; Pakkenberg B; Tanassi JT; Heegaard NH; Winge K
    Parkinsonism Relat Disord; 2012 Aug; 18(7):899-901. PubMed ID: 22503539
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of biomarkers and imaging in Parkinson's disease.
    Algarni MA; Stoessl AJ
    Expert Rev Neurother; 2016; 16(2):187-203. PubMed ID: 26829357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretion of DJ-1 into the serum of patients with Parkinson's disease.
    Maita C; Tsuji S; Yabe I; Hamada S; Ogata A; Maita H; Iguchi-Ariga SM; Sasaki H; Ariga H
    Neurosci Lett; 2008 Jan; 431(1):86-9. PubMed ID: 18162323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic biomarkers for stroke: a stroke neurologist's perspective.
    Hill MD
    Clin Chem; 2005 Nov; 51(11):2001-2. PubMed ID: 16244286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.